Next 10 |
home / stock / adocy / adocy news
Sportsman's Warehouse Holdings Inc. (SPWH) is expected to report $-0.3 for Q4 2024 IDW Media Holdings, Inc. (IDWM) is expected to report for quarter end 2024-01-31 Klepierre (KLPEF) is expected to report for Q4 2023 Steakholder Foods Ltd. (STKH) is expected to report for Q4 2023 R...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
Weir Group plc ADR (WEGRY) is expected to report for Q4 2023 So-Young International Inc. (SY) is expected to report for quarter end 2023-12-31 Atara Biotherapeutics Inc. (ATRA) is expected to report $-0.61 for Q4 2023 Adyen NV ADR (ADYEY) is expected to report for Q4 2023 Five Bel...
Adocia ADR (ADOCY) is expected to report for quarter end 2023-12-31
France's Adocia ( OTC:ADOCY ) said its Chinese partner Tonghua Dongbao noted that a phase 1 trial of BioChaperone Lispro insulin (THDB0206 in China) met its main goal. The company added that BioChaperone Lispro was compared to Eli Lilly's ( NYSE: LLY ) Humalog (insulin li...
Adocia SA press release ( OTC:ADOCY ): Q3 Revenue of €2.4M (+352.8% Y/Y). Cash position of €20.1M as of September 30, 2022, compared to €15.2M as of December 31, 2021. Net financial debt (excluding IFRS 16 impacts and derivative debts) amounted to ...
Adocia ( OTC:ADOCY ) ( OTC:ADOIF ) said a post-hoc analysis of a phase 2 trial showed benefit of M1Pram in weight loss in certain people with obesity and type 1 diabetes (T1D). The company evaluated M1Pram's against Eli Lilly's ( NYSE: LLY ) Humalog (in...
Adocia press release (OTCPK:ADOCY): Q1 €25.3M cash position as of March 31, 2022 Revenue of €0.58M (+383.3% Y/Y). For further details see: Adocia reports Q1 results
Nanjing InxMed announced a $15 million B+ funding round to develop its novel therapies that target the stroma microenvironment and drug resistance for hard-to-treat solid tumors. InxMed will use the funds for US/China clinical trials of its lead drug, IN10018. US-based Coherus Bioscie...
Adocia (OTCPK:ADOCY) (OTC:ADOIF) said its partner Partner Tonghua Dongbao the first patient was dosed with the ultra-rapid insulin BioChaperone Lispro (BC Lispro) in a phase 3 study. Adocia said the event triggers a $5M milestone payment by Tonghua to the company. A maximu...
News, Short Squeeze, Breakout and More Instantly...
Adocia ADR Company Name:
ADOCY Stock Symbol:
OTCMKTS Market:
Sportsman's Warehouse Holdings Inc. (SPWH) is expected to report $-0.3 for Q4 2024 IDW Media Holdings, Inc. (IDWM) is expected to report for quarter end 2024-01-31 Klepierre (KLPEF) is expected to report for Q4 2023 Steakholder Foods Ltd. (STKH) is expected to report for Q4 2023 R...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
Weir Group plc ADR (WEGRY) is expected to report for Q4 2023 So-Young International Inc. (SY) is expected to report for quarter end 2023-12-31 Atara Biotherapeutics Inc. (ATRA) is expected to report $-0.61 for Q4 2023 Adyen NV ADR (ADYEY) is expected to report for Q4 2023 Five Bel...